{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:37:56Z","timestamp":1790087876386,"version":"4.0.1"},"reference-count":108,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009776","name":"McMaster University","doi-asserted-by":"publisher","award":["Alternate Funding Plan (No. 20-10178-480925-75153)"],"award-info":[{"award-number":["Alternate Funding Plan (No. 20-10178-480925-75153)"]}],"id":[{"id":"10.13039\/100009776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-156306"],"award-info":[{"award-number":["PJT-156306"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Institute of St. Joseph\u2019s Studentship Award"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Multimorbidity, the presence of two or more (2+) chronic conditions, presents significant challenges for healthcare delivery, particularly among populations with opioid use disorder (OUD). Multimorbidity patterns among individuals with OUD are not well established, and minimal research exists examining the impact of clustering methods on identifying these patterns.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>Our study aimed to assess multimorbidity prevalence, explore associated sociodemographic and clinical characteristics, and determine multimorbidity patterns using hierarchical cluster analysis (HCA) and K-means clustering among people receiving treatment for OUD in Ontario, Canada between 2011 and 2021.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Data from two prospective cohort studies were merged and linked to Ontario provincial health administrative databases. We identified 16 chronic conditions, used in prior research examining multimorbidity in Ontario, using ICD-10-CA diagnostic codes and the diagnostic codes of physician billing claims using a 2-year lookback. Multimorbidity was defined as the presence of 2+ of the above conditions, excluding the diagnosis of OUD. We conducted a retrospective cohort study, following the participants for eight years in the data holdings to ascertain the prevalence of multimorbidity. Sociodemographic and clinical characteristics were analyzed using modified Poisson regression models, and multimorbidity patterns were identified through HCA and K-means clustering.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Among 3,430 people with OUD, 32.5% (<jats:italic>n<\/jats:italic>\u2009=\u20091,114, 95% confidence interval (CI)=30.9, 34.1) experienced multimorbidity over an eight-year period, with older age (Prevalence Ratio (PR)=3.39, 95% CI\u2009=\u20092.36, 4.87) and unemployment (PR\u2009=\u20091.31, 95% CI\u2009=\u20091.13, 1.54) associated with increased prevalence. HCA identified six distinct disease clusters, whereas K-means clustering identified four clusters. Both methods identified groupings of cardiovascular (coronary syndrome), cardiometabolic (diabetes, hypertension), and respiratory (chronic obstructive pulmonary disease) diseases, reflecting shared comorbidities among people with OUD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>Our findings highlight the substantial burden of multimorbidity among populations with OUD, and the importance of considering sociodemographic factors in understanding multimorbidity prevalence. Moreover, the choice of clustering method significantly influences the identification and interpretation of multimorbidity patterns, with HCA providing more clinically meaningful groupings compared to K-means clustering. Our findings highlight the need for clinicians to tailor care plans and for policymakers to prioritize integrated healthcare delivery strategies to address the complex health needs of people with OUD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0324548","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:02:46Z","timestamp":1749758566000},"page":"e0324548","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative analysis of methods for identifying multimorbidity patterns among people with opioid use disorder: A retrospective single-cohort study"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7953-773X","authenticated-orcid":true,"given":"Myanca","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-4056","authenticated-orcid":true,"given":"Tea","family":"Rosic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Babe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany B.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alannah","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3961-6008","authenticated-orcid":true,"given":"Claire","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Parpia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0355-9734","authenticated-orcid":true,"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"issue":"6","key":"pone.0324548.ref001","doi-asserted-by":"crossref","first-page":"224","DOI":"10.24095\/hpcdp.38.6.02","article-title":"The opioid crisis in Canada: a national perspective","volume":"38","author":"L Belzak","year":"2018","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"pone.0324548.ref002","author":"Public Health Agency of Canada","year":"2024"},{"key":"pone.0324548.ref003","author":"Statistics Canada","year":"2019"},{"key":"pone.0324548.ref004","author":"National Institute on Drug Abuse","year":"2022"},{"key":"pone.0324548.ref005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2296-10-25","article-title":"Chronic illness and multimorbidity among problem drug users: a comparative cross sectional pilot study in primary care","volume":"10","author":"W Cullen","year":"2009","journal-title":"BMC Fam Pract"},{"issue":"5","key":"pone.0324548.ref006","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3122\/jabfm.2015.05.150004","article-title":"Clinical needs of patients with problem drug use","volume":"28","author":"A Krupski","year":"2015","journal-title":"J Am Board Fam Med"},{"issue":"5","key":"pone.0324548.ref007","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/QAI.0b013e31823801c4","article-title":"Control of medical comorbidities in individuals with HIV","volume":"58","author":"AK Monroe","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"pone.0324548.ref008","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/cid\/cir673","article-title":"HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users","volume":"53","author":"ML Salter","year":"2011","journal-title":"Clin Infect Dis"},{"key":"pone.0324548.ref009","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jsat.2017.03.006","article-title":"Chronic pain among patients with opioid use disorder: results from electronic health records data","volume":"77","author":"Y-I Hser","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"pone.0324548.ref010","doi-asserted-by":"crossref","first-page":"209210","DOI":"10.1016\/j.josat.2023.209210","article-title":"Clinical characteristics and prognostic factors among hospitalized patients with substance use disorders: findings from a retrospective cohort study of a Canadian inpatient addiction medicine service","volume":"157","author":"LJ Martin","year":"2024","journal-title":"J Subst Use Addict Treat"},{"key":"pone.0324548.ref011","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/13814789609162146","article-title":"Comorbidity or multimorbidity: what\u2019s in a name? A review of literature","volume":"2","author":"M van den Akker","year":"1996","journal-title":"Eur J Gen Pract"},{"key":"pone.0324548.ref012","doi-asserted-by":"crossref","first-page":"26335565241237889","DOI":"10.1177\/26335565241237889","article-title":"Multimorbidity and chronic pain management with opioids and other therapies among adults in the United States: a cross-sectional study","volume":"14","author":"RA Neba","year":"2024","journal-title":"J Multimorb Comorb"},{"issue":"4","key":"pone.0324548.ref013","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/13814788.2014.905912","article-title":"Methadone-maintained patients in primary care have higher rates of chronic disease and multimorbidity, and use health services more intensively than matched controls","volume":"20","author":"J O\u2019Toole","year":"2014","journal-title":"Eur J Gen Pract"},{"issue":"2","key":"pone.0324548.ref014","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/15504263.2021.1904162","article-title":"Sex differences in opioid use disorder prevalence and multimorbidity nationally in the veterans health administration","volume":"17","author":"MR Peltier","year":"2021","journal-title":"J Dual Diagn"},{"issue":"2","key":"pone.0324548.ref015","first-page":"99","article-title":"Public health surveillance and role of administrative data","volume":"57","author":"AJ Kon\u00e9 P\u00e9foyo","year":"2009","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"3","key":"pone.0324548.ref016","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4212\/cjhp.v68i3.1457","article-title":"An introduction to health care administrative data","volume":"68","author":"SM Cadarette","year":"2015","journal-title":"Can J Hosp Pharm"},{"issue":"7","key":"pone.0324548.ref017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102149","article-title":"Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies","volume":"9","author":"C Violan","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"pone.0324548.ref018","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jclinepi.2013.09.021","article-title":"Multimorbidity patterns: a systematic review","volume":"67","author":"A Prados-Torres","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"pone.0324548.ref019","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","article-title":"Aging with multimorbidity: a systematic review of the literature","volume":"10","author":"A Marengoni","year":"2011","journal-title":"Ageing Res Rev"},{"issue":"3","key":"pone.0324548.ref020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018986","article-title":"Comparative analysis of methods for identifying multimorbidity patterns: a study of \u201creal-world\u201d data","volume":"8","author":"A Roso-Llorach","year":"2018","journal-title":"BMJ Open"},{"key":"pone.0324548.ref021","doi-asserted-by":"crossref","DOI":"10.1002\/9780470977811","volume-title":"Cluster analysis","author":"BS Everitt","year":"2011"},{"issue":"3","key":"pone.0324548.ref022","doi-asserted-by":"crossref","first-page":"163","DOI":"10.22329\/amr.v12i3.658","article-title":"Multimorbidity clusters: clustering binary data from multimorbidity clusters: clustering binary data from a large administrative medical database","volume":"12","author":"JE Cornell","year":"2009","journal-title":"Appl Multivar Res"},{"issue":"4","key":"pone.0324548.ref023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2017.01.027","article-title":"Cluster analysis on longitudinal data of patients with adult-onset asthma","volume":"5","author":"P Ilmarinen","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"pone.0324548.ref024","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12882-016-0238-2","article-title":"Cluster analysis and its application to healthcare claims data: a study of end-stage renal disease patients who initiated hemodialysis","volume":"17","author":"M Liao","year":"2016","journal-title":"BMC Nephrol"},{"issue":"1","key":"pone.0324548.ref025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12875-018-0790-x","article-title":"Multimorbidity patterns with K-means nonhierarchical cluster analysis","volume":"19","author":"C Viol\u00e1n","year":"2018","journal-title":"BMC Fam Pract"},{"issue":"1","key":"pone.0324548.ref026","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12877-018-0705-7","article-title":"Multimorbidity patterns in the elderly: a prospective cohort study with cluster analysis","volume":"18","author":"M Guisado-Clavero","year":"2018","journal-title":"BMC Geriatr"},{"key":"pone.0324548.ref027","doi-asserted-by":"crossref","first-page":"108806","DOI":"10.1016\/j.jsat.2022.108806","article-title":"Multimorbidity classes indicate differential patterns of health care engagement among people who inject drugs","volume":"142","author":"O Heidari","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"pone.0324548.ref028","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11606-013-2660-5","article-title":"Multimorbidity and evidence generation","volume":"29","author":"CO Weiss","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"8","key":"pone.0324548.ref029","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jamda.2015.03.013","article-title":"Aging and multimorbidity: new tasks, priorities, and frontiers for integrated gerontological and clinical research","volume":"16","author":"E Fabbri","year":"2015","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"pone.0324548.ref030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12963-017-0126-4","article-title":"Evidence-based design recommendations for prevalence studies on multimorbidity: improving comparability of estimates","volume":"15","author":"BM Holzer","year":"2017","journal-title":"Popul Health Metr"},{"issue":"12","key":"pone.0324548.ref031","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"E von Elm","year":"2014","journal-title":"Int J Surg"},{"issue":"10","key":"pone.0324548.ref032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"EI Benchimol","year":"2015","journal-title":"PLoS Med"},{"issue":"1","key":"pone.0324548.ref033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0314296","article-title":"Hospital and physician-based mental healthcare during 12 months of opioid agonist treatment for opioid use disorder: exploring costs and factors associated with acute care","volume":"20","author":"T Rosic","year":"2025","journal-title":"PLoS One"},{"key":"pone.0324548.ref034","doi-asserted-by":"crossref","first-page":"209524","DOI":"10.1016\/j.josat.2024.209524","article-title":"Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkage","volume":"167","author":"BB Dennis","year":"2024","journal-title":"J Subst Use Addict Treat"},{"issue":"2","key":"pone.0324548.ref035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmen.0000253","article-title":"A tutorial on the what, why, and how of Bayesian analysis: estimating mood and anxiety disorder prevalence using a Canadian data linkage study","volume":"2","author":"M Rodrigues","year":"2025","journal-title":"PLOS Ment Health"},{"key":"pone.0324548.ref036","doi-asserted-by":"crossref","first-page":"111535","DOI":"10.1016\/j.drugalcdep.2024.111535","article-title":"Impact of Hcv status on healthcare utilization for opioid related harms among patients receiving opioid agonist therapy","volume":"267","author":"P Guyatt","year":"2025","journal-title":"Drug Alcohol Depend"},{"key":"pone.0324548.ref037","doi-asserted-by":"crossref","first-page":"112050","DOI":"10.1016\/j.drugalcdep.2024.112050","article-title":"Health service utilization, substance use treatment and death in patients with opioid use disorder and Hepatitis C: a prospective cohort study with administrative database linkage","volume":"267","author":"B Dennis","year":"2025","journal-title":"Drug Alcohol Depend"},{"key":"pone.0324548.ref038","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2147\/NDT.S66234","article-title":"Genetic influence on methadone treatment outcomes in patients undergoing methadone maintenance treatment for opioid addiction: a pilot study","volume":"10","author":"Z Samaan","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"pone.0324548.ref039","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2147\/NDT.S129480","article-title":"The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study","volume":"13","author":"T Rosic","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"pone.0324548.ref040","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2019.99","article-title":"Exploring psychological symptoms and associated factors in patients receiving medication-assisted treatment for opioid-use disorder","volume":"6","author":"T Rosic","year":"2020","journal-title":"BJPsych Open"},{"issue":"1","key":"pone.0324548.ref041","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044017","article-title":"Are patients\u2019 goals in treatment associated with expected treatment outcomes? Findings from a mixed-methods study on outpatient pharmacological treatment for opioid use disorder","volume":"11","author":"T Rosic","year":"2021","journal-title":"BMJ Open"},{"issue":"4","key":"pone.0324548.ref042","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000939","article-title":"Factors associated with increased opioid use during the COVID-19 pandemic: a prospective study of patients enrolled in opioid agonist treatment","volume":"16","author":"T Rosic","year":"2022","journal-title":"J Addict Med"},{"issue":"4","key":"pone.0324548.ref043","doi-asserted-by":"crossref","DOI":"10.5812\/aapm.119156","article-title":"Full opioid agonists and tramadol: pharmacological and clinical considerations","volume":"11","author":"AN Edinoff","year":"2021","journal-title":"Anesth Pain Med"},{"issue":"9","key":"pone.0324548.ref044","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1360-0443.2011.03463.x","article-title":"Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial","volume":"106","author":"J Reimer","year":"2011","journal-title":"Addiction"},{"issue":"3","key":"pone.0324548.ref045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"WR Martin","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"pone.0324548.ref046","volume-title":"The Chief public health officer\u2019s report on the state of public health in Canada","author":"Canada CPHO, Canada PHA of.","year":"2011"},{"key":"pone.0324548.ref047","volume-title":"Economic burden of illness in Canada, 2005\u20132008","author":"Canada PHA of","year":"2014"},{"key":"pone.0324548.ref048","volume-title":"Global status report on noncommunicable diseases 2010","author":"WHO G","year":"2011"},{"issue":"10","key":"pone.0324548.ref049","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s11136-016-1281-y","article-title":"The relative impact of chronic conditions and multimorbidity on health-related quality of life in Ontario long-stay home care clients","volume":"25","author":"L Mondor","year":"2016","journal-title":"Qual Life Res"},{"key":"pone.0324548.ref050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s12889-015-1733-2","article-title":"The increasing burden and complexity of multimorbidity","volume":"15","author":"AJK Pefoyo","year":"2015","journal-title":"BMC Public Health"},{"issue":"12","key":"pone.0324548.ref051","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.ebiom.2015.11.018","article-title":"Absence of a socioeconomic gradient in older adults\u2019 survival with multiple chronic conditions","volume":"2","author":"NE Lane","year":"2015","journal-title":"EBioMedicine"},{"issue":"1","key":"pone.0324548.ref052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.5368","article-title":"Multimorbidity measures from health administrative data using ICD system codes: a systematic review","volume":"31","author":"M Simard","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pone.0324548.ref053","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/da.23113","article-title":"Co-morbidity between mood and anxiety disorders: a systematic review and meta\u2010analysis","volume":"38","author":"S Saha","year":"2021","journal-title":"Depress Anxiety"},{"issue":"5","key":"pone.0324548.ref054","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archgenpsychiatry.2010.35","article-title":"High occurrence of mood and anxiety disorders among older adults: the national comorbidity survey replication","volume":"67","author":"AL Byers","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"pone.0324548.ref055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243317","article-title":"Evaluating the effectiveness of concurrent opioid agonist treatment and physician-based mental health services for patients with mental disorders in Ontario, Canada","volume":"15","author":"KA Morin","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"pone.0324548.ref056","doi-asserted-by":"crossref","first-page":"737","DOI":"10.17269\/s41997-021-00474-y","article-title":"Rising burden of multimorbidity and related socio-demographic factors: a repeated cross-sectional study of Ontarians","volume":"112","author":"AP Kone","year":"2021","journal-title":"Can J Public Health"},{"issue":"3","key":"pone.0324548.ref057","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00127-021-02157-y","article-title":"The prevalence of physical multimorbidity among people with non-affective psychotic disorders 10 years after first diagnosis: a matched retrospective cohort study","volume":"57","author":"M Rodrigues","year":"2022","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"pone.0324548.ref058","volume-title":"Stata","author":"Stata.","year":"2023"},{"issue":"1","key":"pone.0324548.ref059","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5770\/cgj.23.420","article-title":"Canadian guidelines on opioid use disorder among older adults","volume":"23","author":"LM Rieb","year":"2020","journal-title":"Can Geriatr J"},{"key":"pone.0324548.ref060","doi-asserted-by":"crossref","first-page":"108404","DOI":"10.1016\/j.jsat.2021.108404","article-title":"The cascade of care for opioid use disorder among youth in British Columbia, 2018","volume":"130","author":"E Krebs","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"pone.0324548.ref061","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline","volume":"190","author":"J Bruneau","year":"2018","journal-title":"CMAJ"},{"issue":"12","key":"pone.0324548.ref062","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/jclp.23582","article-title":"Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder","volume":"79","author":"L Wang","year":"2023","journal-title":"J Clin Psychol"},{"issue":"9","key":"pone.0324548.ref063","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/add.13013","article-title":"Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration","volume":"110","author":"DP Kao","year":"2015","journal-title":"Addiction"},{"issue":"12","key":"pone.0324548.ref064","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015941","article-title":"Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions","volume":"5","author":"I Sch\u00e4fer","year":"2010","journal-title":"PLoS One"},{"key":"pone.0324548.ref065","doi-asserted-by":"crossref","DOI":"10.31235\/osf.io\/rjqe3","volume-title":"Cluster analysis stopping rules in Stata","author":"B Halpin","year":"2016"},{"key":"pone.0324548.ref066","volume-title":"Modern multidimensional scaling: theory and applications","author":"I Borg","year":"2005"},{"key":"pone.0324548.ref067","doi-asserted-by":"crossref","DOI":"10.4135\/9781412985130","volume-title":"Multidimensional scaling","author":"JB Kruskal","year":"1978"},{"key":"pone.0324548.ref068","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF02288916","article-title":"Multidimensional scaling: I. Theory and method","volume":"17","author":"WS Torgerson","year":"1952","journal-title":"Psychometrika"},{"key":"pone.0324548.ref069","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jclinepi.2009.08.008","article-title":"Correspondence analysis is a useful tool to uncover the relationships among categorical variables","volume":"63","author":"N Sourial","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"pone.0324548.ref070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.pra.0000351884.83377.e2","article-title":"Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts","volume":"15","author":"A Fareed","year":"2009","journal-title":"J Psychiatr Pract"},{"issue":"5","key":"pone.0324548.ref071","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00019442-200409000-00015","article-title":"Characteristics and treatment outcome of older methadone-maintenance patients","volume":"12","author":"S Firoz","year":"2004","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"pone.0324548.ref072","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5055\/jom.2009.0004","article-title":"The aging methadone maintenance patient: treatment adjustment, long-term success, and quality of life","volume":"5","author":"R Rajaratnam","year":"2009","journal-title":"J Opioid Manag"},{"key":"pone.0324548.ref073","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.drugalcdep.2014.12.019","article-title":"Mortality among older adults with opioid use disorders in the Veteran\u2019s Health Administration, 2000\u20132011","volume":"147","author":"S Larney","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"pone.0324548.ref074","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13722-017-0074-0","article-title":"The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy","volume":"12","author":"L Naji","year":"2017","journal-title":"Addict Sci Clin Pract"},{"issue":"6","key":"pone.0324548.ref075","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/JGP.0b013e31816ff35a","article-title":"The prevalence of mental and physical health disorders among older methadone patients","volume":"16","author":"D Rosen","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"issue":"12","key":"pone.0324548.ref076","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/NMD.0b013e31818ec7ee","article-title":"Changing profile of abused substances by older persons entering treatment","volume":"196","author":"MR Lofwall","year":"2008","journal-title":"J Nerv Ment Dis"},{"issue":"4","key":"pone.0324548.ref077","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/dar.12031","article-title":"Hypertension, chronic obstructive pulmonary disease, diabetes and depression among older methadone maintenance patients in British Columbia","volume":"32","author":"A Maruyama","year":"2013","journal-title":"Drug Alcohol Rev"},{"key":"pone.0324548.ref078","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugpo.2018.06.005","article-title":"Aging, multimorbidity, and substance use disorders: the growing case for integrating the principles of geriatric care and harm reduction","volume":"58","author":"BH Han","year":"2018","journal-title":"Int J Drug Policy"},{"key":"pone.0324548.ref079","article-title":"Do sex differences among adults with opioid use disorder reflect sex-specific vulnerabilities? A study of behavioral health comorbidities, pain, and quality of life","volume":"14","author":"TG Rhee","year":"2020","journal-title":"J Addict Med"},{"key":"pone.0324548.ref080","doi-asserted-by":"crossref","first-page":"106149","DOI":"10.1016\/j.addbeh.2019.106149","article-title":"Childhood adversity and mental health comorbidity in men and women with opioid use disorders","volume":"102","author":"EA Evans","year":"2020","journal-title":"Addict Behav"},{"issue":"9","key":"pone.0324548.ref081","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jhm.2375","article-title":"The characteristics of patients frequently admitted to academic medical centers in the United States","volume":"10","author":"MK Szekendi","year":"2015","journal-title":"J Hosp Med"},{"key":"pone.0324548.ref082","doi-asserted-by":"crossref","first-page":"100938","DOI":"10.1016\/j.eclinm.2021.100938","article-title":"Opioid use disorder and health service utilization among COVID-19 patients in the US: a nationwide cohort from the Cerner Real-World Data","volume":"37","author":"F Qeadan","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"12","key":"pone.0324548.ref083","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40266-021-00893-z","article-title":"Problematic opioid use among older adults: epidemiology, adverse outcomes and treatment considerations","volume":"38","author":"A Dufort","year":"2021","journal-title":"Drugs Aging"},{"issue":"4","key":"pone.0324548.ref084","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3928\/00989134-20160314-04","article-title":"Managing opioid abuse in older adults: clinical considerations and challenges","volume":"42","author":"D Loreck","year":"2016","journal-title":"J Gerontol Nurs"},{"issue":"4","key":"pone.0324548.ref085","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11606-009-1225-0","article-title":"Methadone deaths: risk factors in pain and addicted populations","volume":"25","author":"V Modesto-Lowe","year":"2010","journal-title":"J Gen Intern Med"},{"issue":"5","key":"pone.0324548.ref086","article-title":"Alpha\u2082-adrenergic agonists for the management of opioid withdrawal","volume":"2016","author":"L Gowing","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"7121","key":"pone.0324548.ref087","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"GS Hotamisligil","year":"2006","journal-title":"Nature"},{"issue":"3","key":"pone.0324548.ref088","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000220","article-title":"Chronic obstructive pulmonary disease: effects beyond the lungs","volume":"7","author":"PJ Barnes","year":"2010","journal-title":"PLoS Med"},{"key":"pone.0324548.ref089","article-title":"Opioid complications and side effects","volume":"11","author":"R Benyamin","year":"2008","journal-title":"Pain Physician"},{"issue":"6","key":"pone.0324548.ref090","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4088\/PCC.v10n0609","article-title":"Methadone-associated QTc prolongation: a case report and review of the literature","volume":"10","author":"DW Abramson","year":"2008","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"pone.0324548.ref091","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADM.0000000000000633","article-title":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","author":"C Cunningham","year":"2020","journal-title":"J Addict Med"},{"key":"pone.0324548.ref092","volume-title":"Medications for opioid use disorder: for healthcare and addiction professionals, policymakers, patients, and families. Treatment Improvement Protocol (TIP) series, No. 63. Executive summary","author":"Administration SA, MHS","year":"2018"},{"key":"pone.0324548.ref093","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9343(99)00113-8","article-title":"Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications","volume":"106","author":"A Whelton","year":"1999","journal-title":"Am J Med"},{"issue":"4","key":"pone.0324548.ref094","first-page":"502","article-title":"Nonsteroidal antiinflammatory drugs and risk of gastrointestinal bleeding among patients on hemodialysis","volume":"22","author":"SM Jankovic","year":"2009","journal-title":"J Nephrol"},{"issue":"6","key":"pone.0324548.ref095","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/01.HYP.9.6.561","article-title":"The opioid peptides. A role in hypertension?","volume":"9","author":"G Feuerstein","year":"1987","journal-title":"Hypertension"},{"issue":"1","key":"pone.0324548.ref096","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/08897077.2021.1932698","article-title":"Multidisciplinary treatment of opioid use disorder in primary care using the collaborative care model","volume":"43","author":"CD Brackett","year":"2022","journal-title":"Subst Abus"},{"key":"pone.0324548.ref097","doi-asserted-by":"crossref","first-page":"109123","DOI":"10.1016\/j.drugalcdep.2021.109123","article-title":"Effectiveness of peer recovery support services on stages of the opioid use disorder treatment cascade: a systematic review","volume":"229","author":"MA Gormley","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"pone.0324548.ref098","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-3-030-16257-3_7","article-title":"Mutual help and peer support models for opioid use disorder recovery","volume-title":"Treating opioid addiction","author":"JF Kelly","year":"2019"},{"key":"pone.0324548.ref099","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsat.2019.06.013","article-title":"Emergency department-based peer support for opioid use disorder: emergent functions and forms","volume":"108","author":"AB McGuire","year":"2020","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"pone.0324548.ref100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000312","article-title":"High mortality among patients with opioid use disorder in a large healthcare system","volume":"11","author":"Y-I Hser","year":"2017","journal-title":"J Addict Med"},{"issue":"1","key":"pone.0324548.ref101","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12874-024-02243-0","article-title":"Multimorbidity prevalence and health outcome prediction: assessing the impact of lookback periods, disease count, and definition criteria in health administrative data at the population-based level","volume":"24","author":"M Simard","year":"2024","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"pone.0324548.ref102","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"ME Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"pone.0324548.ref103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12911-015-0155-5","article-title":"Methods for identifying 30 chronic conditions: application to administrative data","volume":"15","author":"M Tonelli","year":"2015","journal-title":"BMC Med Inform Decis Mak"},{"issue":"2","key":"pone.0324548.ref104","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1370\/afm.1363","article-title":"Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide","volume":"10","author":"AL Huntley","year":"2012","journal-title":"Ann Fam Med"},{"issue":"2","key":"pone.0324548.ref105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cjca.2011.10.005","article-title":"Evaluation of care and surveillance of cardiovascular disease: can we trust medico-administrative hospital data?","volume":"28","author":"L Lambert","year":"2012","journal-title":"Can J Cardiol"},{"key":"pone.0324548.ref106","doi-asserted-by":"crossref","first-page":"112451","DOI":"10.1016\/j.drugalcdep.2024.112451","article-title":"Trends in injectable buprenorphine prescribing in Canada: a descriptive analysis in five Canadian Provinces","volume":"264","author":"P Boilard","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"pone.0324548.ref107","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13011-019-0213-6","article-title":"Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada","volume":"14","author":"KA Morin","year":"2019","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"12","key":"pone.0324548.ref108","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s41380-018-0094-5","article-title":"Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis","volume":"24","author":"J Ma","year":"2019","journal-title":"Mol Psychiatry"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0324548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:03:04Z","timestamp":1749758584000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0324548"}},"subtitle":[],"editor":[{"given":"Sairah","family":"Hafeez Kamran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":108,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0324548","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]}}}